PALLADONE Side Effects

6826180-6 | Faecaloma
on Jul 01, 2010 Female patient from GERMANY , 92 years of age, was treated with Palladone (View Usage). Patient experienced the following unwanted or unexpected effects: faecaloma. Palladone dosage: 16 Mg, Daily. During the same period patient was treated with BERLINSULIN /00646002/ (View Berlinsulin /00646002/ Review and Berlinsulin /00646002/ Label ), FUROSEMID /00032601/ (View Furosemid /00032601/ Review and Furosemid /00032601/ Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), LIORESAL (View Lioresal Review and Lioresal Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ). Patient was hospitalized.

6751148-8 | Malignant Neoplasm Progression
Patient was taking Palladone (View Usage). Patient had the following side effects: malignant neoplasm progression on May 26, 2010 from GERMANY Additional patient health information: Male patient , weighting 141.1 lb, was diagnosed with pain (What is pain?) and. Palladone dosage: . Patient was hospitalized.

6729965-X | Blood Creatinine Increased, Blood Sodium Decreased, Dehydration, Hepatotoxicity, Malignant Neoplasm Progression, Narcotic Intoxication, Prostate Cancer
Adverse event was reported on May 17, 2010 by a Male patient taking Palladone (View Usage) (Dosage: 26 Mg, Qid) was diagnosed with pain (What is pain?), prostate cancer (What is prostate cancer?) and. Location: GERMANY , 81 years of age, weighting 149.9 lb, After Palladone was administered, patient had the following side effects: blood creatinine increased, blood sodium decreased, dehydration, hepatotoxicity, malignant neoplasm progression, narcotic intoxication, prostate cancer (What is prostate cancer?). During the same period patient was treated with HYDROMORPHONE HCL (32 Mg, Daily) (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ), PREDNISONE (5 Mg, Bid) (View Prednisone Review and Prednisone Label ), DURAGESIC 100 (Unk) (View Duragesic-100 Review and Duragesic-100 Label ), MOVICOL /01053601/ (View Movicol /01053601/ Review and Movicol /01053601/ Label ), HALDOL (View Haldol Review and Haldol Label ), METAMIZOLE (View Metamizole Review and Metamizole Label ), LYRICA (View Lyrica Review and Lyrica Label ). Patient was hospitalized.

6725432-8 | Dehydration, Hepatotoxicity, Malignant Neoplasm Progression, Narcotic Intoxication
on May 03, 2010 Male patient from GERMANY , 81 years of age, weighting 149.9 lb, was diagnosed with pain (What is pain?), prostate cancer (What is prostate cancer?) and was treated with Palladone (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, hepatotoxicity, malignant neoplasm progression, narcotic intoxication. Palladone dosage: 26 Mg, Qid. During the same period patient was treated with HYDROMORPHONE HCL (32 Mg, Daily) (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ), PREDNISONE TAB (5 Mg, Bid) (View Prednisone Tab Review and Prednisone Tab Label ), DURAGESIC 100 (Unk) (View Duragesic-100 Review and Duragesic-100 Label ), MOVICOL /01053601/ (View Movicol /01053601/ Review and Movicol /01053601/ Label ), HALDOL (View Haldol Review and Haldol Label ), METAMIZOLE (View Metamizole Review and Metamizole Label ), LYRICA (View Lyrica Review and Lyrica Label ). Patient was hospitalized.


6475663-X | Aggression, Anxiety, Delirium, Malignant Neoplasm Progression
on Nov 20, 2009 Male patient from NETHERLANDS , weighting 125.0 lb, was diagnosed with pain (What is pain?), metastatic renal cell carcinoma and was treated with Palladone (View Usage). Patient had the following side effects: aggression, anxiety (What is anxiety?), delirium, malignant neoplasm progression. Palladone dosage: Unk. During the same period patient was treated with RAD001 (10 Mg, Daily) (View Rad001 Review and Rad001 Label ), ETHANOL (View Ethanol Review and Ethanol Label ), METHADONE (Unk) (View Methadone Review and Methadone Label ), AMITRIPTYLINE (Unk) (View Amitriptyline Review and Amitriptyline Label ). Patient was hospitalized.

6475648-3 | Aggression, Anxiety, Delirium, Malignant Neoplasm Progression
Patient was taking Palladone (View Usage). After Palladone was administered, patient had the following side effects: aggression, anxiety (What is anxiety?), delirium, malignant neoplasm progression on Nov 20, 2009 from NETHERLANDS Additional patient health information: Male patient , weighting 125.0 lb, was diagnosed with pain (What is pain?), metastatic renal cell carcinoma and. Palladone dosage: Unk. During the same period patient was treated with RAD001 (10 Mg, Daily) (View Rad001 Review and Rad001 Label ), ETHANOL (View Ethanol Review and Ethanol Label ), METHADONE (Unk) (View Methadone Review and Methadone Label ), AMITRIPTYLINE (Unk) (View Amitriptyline Review and Amitriptyline Label ). Patient was hospitalized.

6252724-1 | Breakthrough Pain
Adverse event was reported on Jun 23, 2009 by a Male patient taking Palladone (View Usage) (Dosage: ) was diagnosed with tumour pain and. Location: GERMANY , 75 years of age, Patient experienced the following unwanted or unexpected effects: breakthrough pain. During the same period patient was treated with TILIDIN N /00628301/ (View Tilidin N /00628301/ Review and Tilidin N /00628301/ Label ). Patient was hospitalized.

6179159-4 | Bladder Catheterisation, Constipation, Dizziness, Gait Disturbance, Hyperhidrosis, Pain, Somnolence
on Apr 20, 2009 Female patient from GERMANY , 45 years of age, weighting 99.21 lb, was diagnosed with cancer pain and was treated with Palladone (View Usage). Patient had the following side effects: bladder catheterisation, constipation (What is constipation?), dizziness (What is dizziness?), gait disturbance, hyperhidrosis, pain (What is pain?), somnolence. Palladone dosage: 36 Mg, Tid. During the same period patient was treated with LYRICA (View Lyrica Review and Lyrica Label ), PALLADON INJEKT (View Palladon Injekt Review and Palladon Injekt Label ), NOVALGIN /00039501/ (View Novalgin /00039501/ Review and Novalgin /00039501/ Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ARCOXIA (View Arcoxia Review and Arcoxia Label ), CLONIDINE (View Clonidine Review and Clonidine Label ).

6017955-4 | Pain, Rectal Haemorrhage
on Mar 03, 2008 Female patient from NETHERLANDS , 87 years of age, was diagnosed with back pain (What is back pain?) and was treated with Palladone (View Usage). After Palladone was administered, patient had the following side effects: pain (What is pain?), rectal haemorrhage. Palladone dosage: 8 Mg, Tid. During the same period patient was treated with OXYCONTIN (20 Mg, Bid) (View Oxycontin Review and Oxycontin Label ). Patient was hospitalized.

6004644-5 | Anxiety, Aphasia, Hallucination, Auditory, Hallucination, Visual
Patient was taking Palladone (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), aphasia (What is aphasia?), hallucination, auditory, hallucination, visual on Dec 09, 2008 from GERMANY Additional patient health information: Female patient , 40 years of age, weighting 116.8 lb, was diagnosed with pain (What is pain?) and. Palladone dosage: 4 Mg, Qid. During the same period patient was treated with MYDOCALM /00293001/ (View Mydocalm /00293001/ Review and Mydocalm /00293001/ Label ).

5963722-7 | Anxiety, Aphasia, Hallucination, Auditory, Hallucination, Visual
Adverse event was reported on Nov 10, 2008 by a Female patient taking Palladone (View Usage) (Dosage: 4 Mg, Qid) was diagnosed with pain (What is pain?) and. Location: GERMANY , 40 years of age, Patient had the following side effects: anxiety (What is anxiety?), aphasia (What is aphasia?), hallucination, auditory, hallucination, visual.

5809722-9 | Periodontitis, Tooth Disorder
on Jul 01, 2008 Female patient from GERMANY , 66 years of age, was diagnosed with pain (What is pain?) and was treated with Palladone (View Usage). After Palladone was administered, patient had the following side effects: periodontitis, tooth disorder (What is tooth disorder?). Palladone dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

5791331-1 | Periodontitis, Tooth Disorder
on Jun 16, 2008 Female patient from GERMANY , 66 years of age, was diagnosed with pain (What is pain?) and was treated with Palladone (View Usage). Patient experienced the following unwanted or unexpected effects: periodontitis, tooth disorder (What is tooth disorder?). Palladone dosage: .

5660953-0 | Pain, Rectal Haemorrhage
Patient was taking Palladone (View Usage). Patient had the following side effects: pain (What is pain?), rectal haemorrhage on Mar 03, 2008 from NETHERLANDS Additional patient health information: Female patient , 87 years of age, was diagnosed with back pain (What is back pain?) and. Palladone dosage: 8 Mg, Tid. During the same period patient was treated with OXYCONTIN (20 Mg, Bid) (View Oxycontin Review and Oxycontin Label ). Patient was hospitalized.

5557282-2 | Increased Upper Airway Secretion, Pneumonia
Adverse event was reported on Dec 06, 2007 by a Male patient taking Palladone (View Usage) (Dosage: 8 Mg, Daily) was diagnosed with cancer pain and. Location: GERMANY , 74 years of age, weighting 143.3 lb, After Palladone was administered, patient had the following side effects: increased upper airway secretion, pneumonia (What is pneumonia?). Patient was hospitalized.

5447728-2 | Anorexia, Apathy, Constipation, Gait Disturbance, Hypercalcaemia, Hypokalaemia
on Aug 29, 2007 Female patient from , 89 years of age, weighting 127.9 lb, was diagnosed with back pain (What is back pain?) and was treated with Palladone (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, apathy, constipation (What is constipation?), gait disturbance, hypercalcaemia, hypokalaemia. Palladone dosage: 8 Mg, Daily. During the same period patient was treated with TORSEMIDE (10 Mg, Bid) (View Torsemide Review and Torsemide Label ), CORVATON ^HOECHST^ (View Corvaton ^hoechst^ Review and Corvaton ^hoechst^ Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), CALCIMAGON D3 (View Calcimagon-d3 Review and Calcimagon-d3 Label ). Patient was hospitalized.

5373930-4 | Prostate Cancer
on Jun 18, 2007 Male patient from , 82 years of age, was treated with Palladone (View Usage). Patient had the following side effects: prostate cancer (What is prostate cancer?). Palladone dosage: 26 Mg, Daily. During the same period patient was treated with ZOLADEX (View Zoladex Review and Zoladex Label ), NAPROSYN (500 Mg, Bid) (View Naprosyn Review and Naprosyn Label ).

5373593-8 | Stevens-johnson Syndrome, Tongue Disorder
Patient was taking Palladone (View Usage). After Palladone was administered, patient had the following side effects: stevens-johnson syndrome, tongue disorder on Jun 15, 2007 from Additional patient health information: Female patient , 60 years of age, . Palladone dosage: 1.3 Mg, Bid.

5356286-2 | Burning Sensation, Dyspnoea, Feeling Hot, Hospitalisation, Hyperaesthesia, Musculoskeletal Stiffness, Pain Of Skin
Adverse event was reported on Jun 08, 2007 by a Male patient taking Palladone (View Usage) (Dosage: 12 Mg, Single) was diagnosed with neuralgia and. Location: , 51 years of age, Patient experienced the following unwanted or unexpected effects: burning sensation, dyspnoea, feeling hot, hospitalisation, hyperaesthesia, musculoskeletal stiffness, pain of skin. Patient was hospitalized.

5352790-1 | Burning Sensation, Dyspnoea, Feeling Hot, Hospitalisation, Hyperaesthesia, Musculoskeletal Stiffness, Pain Of Skin
on Jun 04, 2007 Male patient from , 51 years of age, was diagnosed with neuralgia and was treated with Palladone (View Usage). Patient had the following side effects: burning sensation, dyspnoea, feeling hot, hospitalisation, hyperaesthesia, musculoskeletal stiffness, pain of skin. Palladone dosage: 12 Mg, Single. Patient was hospitalized.

5254340-7 | Angiopathy, Burning Sensation, Dyspnoea, Feeling Hot, Hyperaesthesia, Musculoskeletal Stiffness, Pain Of Skin
on Feb 23, 2007 Male patient from , 51 years of age, was diagnosed with neuralgia and was treated with Palladone (View Usage). After Palladone was administered, patient had the following side effects: angiopathy, burning sensation, dyspnoea, feeling hot, hyperaesthesia, musculoskeletal stiffness, pain of skin. Palladone dosage: 12 Mg, Single.

5211649-0 | Burning Sensation, Dyspnoea, Feeling Hot, Musculoskeletal Stiffness
Patient was taking Palladone (View Usage). Patient experienced the following unwanted or unexpected effects: burning sensation, dyspnoea, feeling hot, musculoskeletal stiffness on Jan 03, 2007 from Additional patient health information: Male patient , 51 years of age, was diagnosed with neuralgia and. Palladone dosage: 12 Mg, Single.

5156936-X | Hospitalisation, No Adverse Effect
Adverse event was reported on Oct 11, 2006 by a Female patient taking Palladone (View Usage) (Dosage: 8 Mg, Bid) was diagnosed with cancer pain and. Location: , 74 years of age, weighting 108.0 lb, Patient had the following side effects: hospitalisation, no adverse effect. During the same period patient was treated with NOVALGIN (View Novalgin Review and Novalgin Label ), MOVICOL (View Movicol Review and Movicol Label ). Patient was hospitalized.

5133039-1 | Acute Pulmonary Oedema, Cardiac Failure, Respiratory Depression
on Oct 12, 2006 Male patient from , 85 years of age, was diagnosed with pain (What is pain?) and was treated with Palladone (View Usage). After Palladone was administered, patient had the following side effects: acute pulmonary oedema, cardiac failure, respiratory depression. Palladone dosage: 16 Mg, Bid. During the same period patient was treated with DIPIPERON (10 Mg, Tid) (View Dipiperon Review and Dipiperon Label ).

5127144-3 | Retrograde Amnesia
on Oct 02, 2006 Female patient from , 45 years of age, was diagnosed with neuralgia, antiviral prophylaxis, bowel movement irregularity and was treated with Palladone (View Usage). Patient experienced the following unwanted or unexpected effects: retrograde amnesia. Palladone dosage: 24 Mg, Bid. During the same period patient was treated with NEURONTIN (1200 Mg, Tid) (View Neurontin Review and Neurontin Label ), TRIPTYL (50 Mg, Daily) (View Triptyl Review and Triptyl Label ), VALTREX (1 Gram, Bid) (View Valtrex Review and Valtrex Label ), MOVICOL (1 Sachet, Bid) (View Movicol Review and Movicol Label ).

5072816-2 | Fatigue, Hepatic Function Abnormal, Malaise, Ocular Icterus, Renal Impairment, Urine Output Decreased
Patient was taking Palladone (View Usage). Patient had the following side effects: fatigue, hepatic function abnormal, malaise, ocular icterus, renal impairment, urine output decreased on Jul 19, 2006 from SLOVAKIA (Slovak Republic) Additional patient health information: Male patient , 54 years of age, was diagnosed with pain (What is pain?) and. Palladone dosage: 8 Mg Twice Oral. During the same period patient was treated with FAMOSAN (FAMOTIDINE) (View Famosan (famotidine) Review and Famosan (famotidine) Label ), TRIMEPRANOL (METIPRANOLOL) (View Trimepranol (metipranolol) Review and Trimepranol (metipranolol) Label ), SILYMARIN (View Silymarin Review and Silymarin Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), DETRALEX (DIOSMIN, HESPERIDIN) (View Detralex (diosmin, Hesperidin) Review and Detralex (diosmin, Hesperidin) Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PREDUCTAL (TRIMETAZIDINE) (View Preductal (trimetazidine) Review and Preductal (trimetazidine) Label ), KANAVIT (PHYTOMENADIONE) (View Kanavit (phytomenadione) Review and Kanavit (phytomenadione) Label ). Patient was hospitalized.

5003871-3 | Meningioma, Restlessness, Sleep Walking
Adverse event was reported on Apr 26, 2006 by a Female patient taking Palladone (View Usage) (Dosage: See Image) was diagnosed with pain (What is pain?) and. Location: GERMANY , 76 years of age, weighting 138.9 lb, After Palladone was administered, patient had the following side effects: meningioma, restlessness, sleep walking. During the same period patient was treated with KATADOLON(FLUPIRTINE MALEATE) (1 Unit, Tid, Oral) (View Katadolon(flupirtine Maleate) Review and Katadolon(flupirtine Maleate) Label ), AMITRIPTYLINE HYDROCHLORIDE (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ), BELOC ZOC MITE (METOPROLOL SUCCINATE) (View Beloc-zoc Mite (metoprolol Succinate) Review and Beloc-zoc Mite (metoprolol Succinate) Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), NOVALGIN (View Novalgin Review and Novalgin Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), RISPERDAL (View Risperdal Review and Risperdal Label ). Patient was hospitalized.

5003870-1 | Coordination Abnormal, Dehydration, Dementia, Disorientation, Haematoma, Hypogammaglobulinaemia, Hyponatraemia, Mobility Decreased
on Apr 27, 2006 Female patient from GERMANY , 76 years of age, weighting 138.9 lb, was treated with Palladone (View Usage). Patient experienced the following unwanted or unexpected effects: coordination abnormal, dehydration, dementia (What is dementia?), disorientation, haematoma, hypogammaglobulinaemia, hyponatraemia, mobility decreased. Palladone dosage: See Image. During the same period patient was treated with AMITRIPTYLINE HYDROCHLORIDE (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ), BELOC ZOC MITE (METOPROLOL SUCCINATE) (View Beloc-zoc Mite (metoprolol Succinate) Review and Beloc-zoc Mite (metoprolol Succinate) Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), NOVALGIN (View Novalgin Review and Novalgin Label ), MOVICOL (SODIUM BICARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACR (View Movicol (sodium Bicarbonate, Potassium Chloride, Sodium Chloride, Macr Review and Movicol (sodium Bicarbonate, Potassium Chloride, Sodium Chloride, Macr Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), RISPERDAL (View Risperdal Review and Risperdal Label ). Patient was hospitalized.

4975568-7 | Cheyne-stokes Respiration, Eye Movement Disorder, Pupil Fixed, Simple Partial Seizures, Somnolence
on Mar 30, 2006 Male patient from GERMANY , 89 years of age, was diagnosed with post herpetic neuralgia and was treated with Palladone (View Usage). Patient had the following side effects: cheyne-stokes respiration, eye movement disorder, pupil fixed, simple partial seizures, somnolence. Palladone dosage: 8 Mg, Qid, Oral. During the same period patient was treated with NEURONTIN (600 Mg, Qid, Oral) (View Neurontin Review and Neurontin Label ).

4950364-5 | Device Failure, Fall, Femoral Neck Fracture
Patient was taking Palladone (View Usage). After Palladone was administered, patient had the following side effects: device failure, fall (What is fall?), femoral neck fracture on Feb 28, 2006 from GERMANY Additional patient health information: Female patient , 88 years of age, weighting 101.4 lb, was diagnosed with pain (What is pain?) and. Palladone dosage: 4 Mg, Bid, Oral. During the same period patient was treated with DIPYRONE TAB (View Dipyrone Tab Review and Dipyrone Tab Label ), LACTULOSE (View Lactulose Review and Lactulose Label ). Patient was hospitalized.

4950343-8 | Meningioma, Pollakiuria, Restlessness, Sleep Walking
Adverse event was reported on Feb 28, 2006 by a Female patient taking Palladone (View Usage) (Dosage: 95 Mg, Daily, Oral : See Text, Oral) was diagnosed with pain (What is pain?) and. Location: GERMANY , 75 years of age, Patient experienced the following unwanted or unexpected effects: meningioma, pollakiuria, restlessness, sleep walking. During the same period patient was treated with DIPYRONE TAB (View Dipyrone Tab Review and Dipyrone Tab Label ), AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ). Patient was hospitalized.

4944723-4 | Asthma, Confusional State, Cough, Depression, Diarrhoea, Dyspnoea, Dysuria, Gastrointestinal Disorder
on Dec 13, 2005 Female patient from UNITED STATES , 54 years of age, was diagnosed with back pain (What is back pain?) and was treated with Palladone (View Usage). Patient had the following side effects: asthma (What is asthma?), confusional state, cough, depression (What is depression?), diarrhoea, dyspnoea, dysuria, gastrointestinal disorder. Palladone dosage: 12 Mg, Q24h, Oral. During the same period patient was treated with TIAZAC (View Tiazac Review and Tiazac Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ZETIA (View Zetia Review and Zetia Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), MENSET MONARCH (View Menset Monarch Review and Menset Monarch Label ).

4887567-4 | Meningioma, Pollakiuria, Restlessness, Sleep Walking
on Jan 03, 2006 Female patient from GERMANY , 75 years of age, was diagnosed with pain (What is pain?) and was treated with Palladone (View Usage). After Palladone was administered, patient had the following side effects: meningioma, pollakiuria, restlessness, sleep walking. Palladone dosage: See Image. During the same period patient was treated with KATADOLON(FLUPIRTINE MALEATE) (1 Unit, Tid, Oral) (View Katadolon(flupirtine Maleate) Review and Katadolon(flupirtine Maleate) Label ), DIPYRONE TAB (View Dipyrone Tab Review and Dipyrone Tab Label ), NORTRIPTYLINE HCL (View Nortriptyline Hcl Review and Nortriptyline Hcl Label ). Patient was hospitalized.

4867877-7 | Blister, Urticaria
Patient was taking Palladone (View Usage). Patient experienced the following unwanted or unexpected effects: blister, urticaria on Dec 12, 2005 from GERMANY Additional patient health information: Female patient , 46 years of age, weighting 163.1 lb, was diagnosed with fibromyalgia and. Palladone dosage: 8 Mg, Bid, Oral. During the same period patient was treated with TRAMUNDIN TROPFEN N (TRAMADOL HYDROCHLORIDE) (View Tramundin Tropfen N (tramadol Hydrochloride) Review and Tramundin Tropfen N (tramadol Hydrochloride) Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ), CELEBREX (View Celebrex Review and Celebrex Label ), MAXALT (TRIZATRIPTAN BENZOATE) (View Maxalt (trizatriptan Benzoate) Review and Maxalt (trizatriptan Benzoate) Label ). Patient was hospitalized.

4859446-X | Pathological Fracture, Upper Limb Fracture
Adverse event was reported on Nov 24, 2005 by a Female patient taking Palladone (View Usage) (Dosage: 4 Mg, Tid; Oral, 8 Mg, Tid, Oral, 8 Mg, Bid, Oral) was diagnosed with cancer pain and. Location: GERMANY , 80 years of age, weighting 156.5 lb, Patient had the following side effects: pathological fracture, upper limb fracture. During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), METAMIZOLE (View Metamizole Review and Metamizole Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), MOVICOL (SODIUM BICARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACR (View Movicol (sodium Bicarbonate, Potassium Chloride, Sodium Chloride, Macr Review and Movicol (sodium Bicarbonate, Potassium Chloride, Sodium Chloride, Macr Label ). Patient was hospitalized.

4859165-X | Epilepsy, Fall, Treatment Noncompliance, Unevaluable Event
on Nov 30, 2005 Female patient from GERMANY , 54 years of age, weighting 198.4 lb, was diagnosed with cancer pain and was treated with Palladone (View Usage). After Palladone was administered, patient had the following side effects: epilepsy (What is epilepsy?), fall (What is fall?), treatment noncompliance, unevaluable event. Palladone dosage: 8 Mg, Bid; Oral. During the same period patient was treated with UNIPHYLLIN RETARD/TABLETTEN (THEOPHYLLIN) CR TABLET (Oral) (View Uniphyllin Retard/tabletten (theophyllin) Cr Tablet Review and Uniphyllin Retard/tabletten (theophyllin) Cr Tablet Label ), FORMOTEROL (View Formoterol Review and Formoterol Label ), ANTI ASTHMATICS (View Anti-asthmatics Review and Anti-asthmatics Label ), TRANDOLAPRIL (View Trandolapril Review and Trandolapril Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ), VIGANTOLETTEN ^MERCK^ (COLECALCIFEROL) (View Vigantoletten ^merck^ (colecalciferol) Review and Vigantoletten ^merck^ (colecalciferol) Label ). Patient was hospitalized.

4853669-1 | Constipation, Faecaloma, Ischaemic Ulcer, Rectal Ulcer
on Nov 28, 2005 Female patient from GERMANY , 77 years of age, was diagnosed with cancer pain and was treated with Palladone (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), faecaloma, ischaemic ulcer, rectal ulcer. Palladone dosage: 4 Mg, Bid, Oral. During the same period patient was treated with BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), MADOPAR (LEVODOPA, BENSERAZIDE HYDROCHLORIDE) (View Madopar (levodopa, Benserazide Hydrochloride) Review and Madopar (levodopa, Benserazide Hydrochloride) Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), LACTULOSE (View Lactulose Review and Lactulose Label ). Patient was hospitalized.

4842200-2 | Fatigue, Impaired Work Ability, Insomnia, Weight Increased
Patient was taking Palladone (View Usage). Patient had the following side effects: fatigue, impaired work ability, insomnia, weight increased on Nov 14, 2005 from GERMANY Additional patient health information: Female patient , 53 years of age, weighting 183.0 lb, was diagnosed with pain (What is pain?) and. Palladone dosage: See Image. During the same period patient was treated with PIROXICAM (View Piroxicam Review and Piroxicam Label ), SALOFALK ^FALK^ (MESALAZINE) (View Salofalk ^falk^ (mesalazine) Review and Salofalk ^falk^ (mesalazine) Label ), NEXIUM (View Nexium Review and Nexium Label ), MINOCYCLINE HCL (View Minocycline Hcl Review and Minocycline Hcl Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ), DROSPIRENONE (DROSPIRENONE) (View Drospirenone (drospirenone) Review and Drospirenone (drospirenone) Label ), REMIFEMIN (CIMICIFUGA /RACEMOSA ROOT) (View Remifemin (cimicifuga /racemosa Root) Review and Remifemin (cimicifuga /racemosa Root) Label ). Patient was hospitalized.

4840403-4 | Agitation, Anxiety, Dehydration, Diarrhoea, Nausea, Pain, Paranoia, Tremor
Adverse event was reported on Aug 23, 2005 by a Female patient taking Palladone (View Usage) (Dosage: 12 Mg, Daily) was diagnosed with pain (What is pain?) and. Location: UNITED STATES , 28 years of age, After Palladone was administered, patient had the following side effects: agitation, anxiety (What is anxiety?), dehydration, diarrhoea, nausea (What is nausea?), pain (What is pain?), paranoia, tremor. Patient was hospitalized.

4840402-2 | Confusional State, Depression, Diarrhoea, Dyspnoea, Dysuria, Gastrointestinal Disorder, Panic Attack, Pruritus
on Jul 26, 2005 Female patient from UNITED STATES , 54 years of age, was diagnosed with pain (What is pain?) and was treated with Palladone (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, depression (What is depression?), diarrhoea, dyspnoea, dysuria, gastrointestinal disorder, panic attack, pruritus. Palladone dosage: 12 Mg, Q24h, Oral. During the same period patient was treated with TIAZAC (View Tiazac Review and Tiazac Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ZETIA (View Zetia Review and Zetia Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), MENEST ^MONARCH^ (View Menest ^monarch^ Review and Menest ^monarch^ Label ).

4840400-9 | Malaise, Renal Impairment, Respiratory Depression, Somnolence
on Jul 25, 2005 Male patient from UNITED STATES , 49 years of age, was diagnosed with pain (What is pain?) and was treated with Palladone (View Usage). Patient had the following side effects: malaise, renal impairment, respiratory depression, somnolence. Palladone dosage: 24 Mg, Q24h, Oral. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

4840399-5 | Polysubstance Abuse
Patient was taking Palladone (View Usage). After Palladone was administered, patient had the following side effects: polysubstance abuse on Jul 25, 2005 from UNITED STATES Additional patient health information: Male patient , 24 years of age, weighting 164.9 lb, . Palladone dosage: 12 Mg, See Text. During the same period patient was treated with OXYCONTIN (View Oxycontin Review and Oxycontin Label ), PERCOCET 5 (View Percocet-5 Review and Percocet-5 Label ), HEROIN (DIAMORPHINE) (View Heroin (diamorphine) Review and Heroin (diamorphine) Label ).

4840398-3 | Migraine, Somnolence
Adverse event was reported on Jun 27, 2005 by a Female patient taking Palladone (View Usage) (Dosage: 12 Mg, Q24h, Oral) was diagnosed with pain (What is pain?) and. Location: UNITED STATES , 61 years of age, Patient experienced the following unwanted or unexpected effects: migraine (What is migraine?), somnolence. Patient was hospitalized.

4840395-8 | Abdominal Pain, Amnesia, Chest Pain, Constipation, Dizziness, Dyspnoea, Flatulence
on Jul 19, 2005 Male patient from UNITED STATES , 42 years of age, was diagnosed with pain (What is pain?) and was treated with Palladone (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), amnesia, chest pain (What is chest pain?), constipation (What is constipation?), dizziness (What is dizziness?), dyspnoea, flatulence. Palladone dosage: 64 Mg, Daily, Oral. During the same period patient was treated with OXYCONTIN (640 Mg, Q12h) (View Oxycontin Review and Oxycontin Label ), ELAVIL (View Elavil Review and Elavil Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), MIGRANAL (View Migranal Review and Migranal Label ).

4825273-2 | Akinesia, Anxiety, Fall, Hallucination, Auditory, Loss Of Consciousness, Parosmia, Sleep Attacks
on Oct 28, 2005 Female patient from GERMANY , 49 years of age, was diagnosed with pain (What is pain?) and was treated with Palladone (View Usage). After Palladone was administered, patient had the following side effects: akinesia, anxiety (What is anxiety?), fall (What is fall?), hallucination, auditory, loss of consciousness, parosmia, sleep attacks. Palladone dosage: 12 Mg, Bid, Oral. During the same period patient was treated with MARCUMAR (View Marcumar Review and Marcumar Label ), AMINEURIN (AMITRIPTYLINE HYDROCHLORIDE) (View Amineurin (amitriptyline Hydrochloride) Review and Amineurin (amitriptyline Hydrochloride) Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), THYROJOD (POTASSIUM IODIDE) (View Thyrojod (potassium Iodide) Review and Thyrojod (potassium Iodide) Label ). Patient was hospitalized.

4817593-2 | Fall, Loss Of Consciousness
Patient was taking Palladone (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), loss of consciousness on Oct 17, 2005 from GERMANY Additional patient health information: Female patient , 49 years of age, was diagnosed with pain (What is pain?) and. Palladone dosage: 12 Mg, Bid, Oral. Patient was hospitalized.

4799541-7 | Fatigue, Impaired Work Ability, Insomnia, Pruritus
Adverse event was reported on Sep 26, 2005 by a Female patient taking Palladone (View Usage) (Dosage: See Image) was diagnosed with pain (What is pain?) and. Location: GERMANY , 53 years of age, Patient had the following side effects: fatigue, impaired work ability, insomnia, pruritus. During the same period patient was treated with PIROXICAM (View Piroxicam Review and Piroxicam Label ).

4750199-2 | Depressed Level Of Consciousness, Diabetic Ketoacidosis, Insomnia, Loss Of Consciousness, Overdose
on Aug 15, 2005 Male patient from UNITED STATES , 36 years of age, weighting 313.9 lb, was diagnosed with pain (What is pain?), insomnia and was treated with Palladone (View Usage). After Palladone was administered, patient had the following side effects: depressed level of consciousness, diabetic ketoacidosis, insomnia, loss of consciousness, overdose. Palladone dosage: 168 Mg, Hs, Oral. During the same period patient was treated with HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ), KEPPRA (GABAPENTIN) (View Keppra (gabapentin) Review and Keppra (gabapentin) Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), AMBIEN (View Ambien Review and Ambien Label ). Patient was hospitalized.

4746175-6 | Diabetic Ketoacidosis, Insomnia, Loss Of Consciousness, Overdose
on Aug 09, 2005 Male patient from UNITED STATES , 36 years of age, weighting 313.9 lb, was diagnosed with pain (What is pain?), insomnia and was treated with Palladone (View Usage). Patient experienced the following unwanted or unexpected effects: diabetic ketoacidosis, insomnia, loss of consciousness, overdose. Palladone dosage: 168 Mg, Hs, Oral. During the same period patient was treated with HYDROMORPHONE HYDROCHLORIDE (View Hydromorphone Hydrochloride Review and Hydromorphone Hydrochloride Label ), AMBIEN (View Ambien Review and Ambien Label ), KEPPRA (View Keppra Review and Keppra Label ), NEURONTIN (View Neurontin Review and Neurontin Label ). Patient was hospitalized.

4732433-8 | Confusional State, Dizziness, Hypersomnia, Memory Impairment
Patient was taking Palladone (View Usage). Patient had the following side effects: confusional state, dizziness (What is dizziness?), hypersomnia, memory impairment on Jul 26, 2005 from UNITED STATES Additional patient health information: Female patient , 47 years of age, was diagnosed with pain (What is pain?) and. Palladone dosage: See Image. During the same period patient was treated with REGLAN (View Reglan Review and Reglan Label ), XANAX (View Xanax Review and Xanax Label ), ZELNORM (View Zelnorm Review and Zelnorm Label ), DONNATAL ELIXIR (ATROPINE SULFATE, PHENOBARBITAL, HYOSCINE HYDROBROMID (View Donnatal Elixir (atropine Sulfate, Phenobarbital, Hyoscine Hydrobromid Review and Donnatal Elixir (atropine Sulfate, Phenobarbital, Hyoscine Hydrobromid Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), PREMARIN (View Premarin Review and Premarin Label ), ACIFEX (View Acifex Review and Acifex Label ), SOMA (View Soma Review and Soma Label ).